Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02502695 · ClinicalTrials.gov registry record
A Study to Optimize Care for Lung Cancer Patients Undergoing Video-Assisted Thoracoscopic Surgery (VATS)
A clinical trial, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- 173
- Enrollment target
NCT02502695: Completed study, sponsored by Dana-Farber Cancer Institute.
NCT02502695 is a clinical trial that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 173 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02502695 has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- 173 participants
- Enrollment target
Study Summary
This is a research study for participants who have been diagnosed with lung cancer and are receiving VATS (Video Assisted Thoracoscopic Surgery) lobectomy or segmentectomy. The overall objective of this study is to develop a database to collect data on participants who are undergoing VATS lobectomy or segmentectomy for lung cancer.
Interventions
- OTHER VATS-associated best practices
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 173 participants |
| Start Date | 2015-06 |
| Est. Completion | 2019-05 |
What the finished NCT02502695 record still lists
NCT02502695 is an observational study that tracks outcomes without assigning an intervention. The registered 173 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which VATS-associated best practices is the first listed.
NCT02502695 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02502695 about?
NCT02502695 is a clinical study titled "A Study to Optimize Care for Lung Cancer Patients Undergoing Video-Assisted Thoracoscopic Surgery (VATS)". This is a research study for participants who have been diagnosed with lung cancer and are receiving VATS (Video Assisted Thoracoscopic Surgery) lobectomy or segmentectomy. The overall objective of this study is to develop a database to collect data on participants who are undergoing VATS lobectomy ...
What is the current status of trial NCT02502695?
This trial is currently completed. The enrollment target is 173 participants. The study started on 2015-06. Estimated completion is 2019-05.
What interventions are being tested in trial NCT02502695?
The interventions under investigation include: VATS-associated best practices (OTHER).
Who is sponsoring clinical trial NCT02502695?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05568719 · 173 participants · Phase 3
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
- NCT07070115 · 173 participants · NA
Evaluating Clinical Hiatal Hernia Outcomes Using OviTex®
- NCT07150832 · 173 participants · NA
Efficacy of the I-CARE Digital Health Intervention
- NCT01000259 · 174 participants
Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia